Correlation Between NVIDIA CDR and Cardiol Therapeutics

Can any of the company-specific risk be diversified away by investing in both NVIDIA CDR and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NVIDIA CDR and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NVIDIA CDR and Cardiol Therapeutics Class, you can compare the effects of market volatilities on NVIDIA CDR and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NVIDIA CDR with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NVIDIA CDR and Cardiol Therapeutics.

Diversification Opportunities for NVIDIA CDR and Cardiol Therapeutics

0.72

Correlation Coefficient

NVIDIA CDR  Cardiol Therapeutics

Poor diversification

The 3 months correlation between NVIDIA and Cardiol is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding NVIDIA CDR and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and NVIDIA CDR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NVIDIA CDR are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of NVIDIA CDR i.e., NVIDIA CDR and Cardiol Therapeutics go up and down completely randomly.

Pair Corralation between NVIDIA CDR and Cardiol Therapeutics

Assuming the 90 days trading horizon NVIDIA CDR is expected to generate 0.46 times more return on investment than Cardiol Therapeutics. However, NVIDIA CDR is 2.17 times less risky than Cardiol Therapeutics. It trades about 0.46 of its potential returns per unit of risk. Cardiol Therapeutics Class is currently generating about 0.07 per unit of risk. If you would invest  2,369  in NVIDIA CDR on April 23, 2025 and sell it today you would earn a total of  1,564  from holding NVIDIA CDR or generate 66.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.41%
Values	Daily Returns

NVIDIA CDR  vs.  Cardiol Therapeutics Class

NVIDIA CDR

Risk-Adjusted Performance

Very Strong

Compared to the overall equity markets, risk-adjusted returns on investments in NVIDIA CDR are ranked lower than 35 (%) of all global equities and portfolios over the last 90 days. In spite of rather abnormal technical and fundamental indicators, NVIDIA CDR exhibited solid returns over the last few months and may actually be approaching a breakup point.

Cardiol Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cardiol Therapeutics Class are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Cardiol Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NVIDIA CDR and Cardiol Therapeutics

The main advantage of trading using opposite NVIDIA CDR and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NVIDIA CDR position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.

The idea behind NVIDIA CDR and Cardiol Therapeutics Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.